BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Drug Development

  Menopause and Estrogen Decline Could Show a Link to Alzheimer’s Disease

  As pharma companies struggle with developing a treatment for Alzheimer’s disease, researchers continue to find evidence that links the dreaded form of dementia to other medical and health issues. The latest news suggests a potential link between Alzheimer’s and menopause.

  February 19, 2019

   · 

  2 min read

   · 

  Alex Keown
• Business

  MDxHealth (R): MDxHealth Appoints Michael K. McGarrity as CEO

  MDxHealth SA announced the appointment of Michael K. McGarrity to the position of Chief Executive Officer and member of the Board of Directors effective February 19, 2019.

  February 19, 2019

   · 

  4 min read
• Business

  Nutricion Center NC and ADL Bionatur Solutions sign a strategic alliance to tackle weight control by rebalancing the gut microbiome

  ADL Bionatur Solutions, by partnering with Nutricion Center NC, opens up big opportunities in the Spanish pharmacy sector: reaching over 2,000 direct sales points; and 20,000 pharmacies

  February 19, 2019

   · 

  4 min read
• FDA

  Medtronic Receives FDA Breakthrough Designation for Developing Personalized Closed Loop Insulin Pump System for Diabetes Management

  Medtronic plc, the global leader in medical technology, announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration for its Personalized Closed Loop insulin pump system, currently in development.

  February 19, 2019

   · 

  2 min read
• Business

  Medtronic Reports 2019 Third Quarter Financial Results

  Medtronic plc announced financial results for its third quarter of fiscal year 2019, which ended January 25, 2019.

  February 19, 2019

   · 

  13 min read
• Business

  Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire

  Simon Moroney, CEO and co-founder of MorphoSys AG informed the Company’s Supervisory Board that he has decided not to renew his contract as a member of the company’s Management Board.

  February 19, 2019

   · 

  6 min read
• 

  Job Trends

  AveXis to Expand Its NC Manufacturing Facility, Plans to Hire 200

  On Monday, N.C. Gov. Roy Cooper announced the expansion to the company’s Durham facility that was first announced in May 2018. It’s expected to provide up to 200 additional jobs.

  February 19, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Inventiva Discontinues Systemic Sclerosis Drug After Mid-Stage Flop

  Shares of France-based Inventiva have plunged more than 45 percent after the company reported that its experimental treatment for a rare autoimmune disease failed to hit primary and secondary endpoints in a mid-stage trial.

  February 19, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Japanese Researchers Will Use Stem Cells to Treat Spinal Cord Injuries in Groundbreaking Clinical Trial

  Four patients with spinal cord injuries will receive nerve cells made from induce pluripotent stem cells in hopes of regaining sensation and mobility lost as a result of the injury.

  February 19, 2019

   · 

  2 min read

   · 

  Alex Keown
• New Center of Competence for Innovative Diabetes Therapy (KomIT) is funded by NRW and EU

  The Lead Discovery Center is part of a new consortium of eight partners from industry and academia focusing on the development of new diabetes therapies.

  February 19, 2019

   · 

  3 min read